Abstract:Type 2 diabetes mellitus (T2DM) is a growing burden in low‐and middle‐income countries. Changing lifestyles and lack of physical activity are some of the reasons contributing to this epidemic increase. Co‐morbidities associated with T2DM are largely due to the complications which arise as a consequence of endothelial dysfunction. Platelet derived growth factor‐alpha (PDGFRA) is a protein responsible for cell proliferation, angiogenesis, migration and invasion. Increased levels of PDGFRA have been reported in T2DM. This study assessed the epigenetic regulation of PDGFRA through microRNAs (miR‐181a/b‐5p).Using a bioinformatics‐based approach, we assessed the binding of miR‐181a/b‐5p to PDGFRA. Experimentally, this binding was confirmed using a dual luciferase reporter assay. Further, we overexpressed miR‐181a/b‐5p in Human umbilical vein endothelial cells (HUVECs) and the influence of over‐expression on cell proliferation, migration and angiogenesis was assessed using in‐vitro approaches. The influence of miR‐181a/b‐5p over expression on cellular apoptosis was ascertained using a TUNEL assay with concomitant changes being observed in the levels of Bcl‐2 and cleaved Caspase‐3.In HUVECs, PDGFRA is a direct target for miR‐181a/b‐5p. Over expression of miR‐181a/b‐5p decreased cellular proliferation, migration, invasion, and tube formation—a surrogate marker for angiogenesis. miR‐181a/b‐5p may be used as a therapeutic intervention to restrict uncontrolled levels of PDGFRA and thereby rescue the phenotypes of increased cell proliferation, migration, invasion and tube formation. miR‐181a/b negatively regulates PDGFRA levels.Significance of the study: T2DM and its associated complications emerge from endothelial dysfunction. The associated phenotypes are regulated by a number of proteins, one such member being, PDGFRA. PDGFRA is in turn regulated by miR‐181a/b‐5p. Complementation with miR‐181a/b‐5p resulted in reversion of phenotypes. Thus, miR‐181a/b‐5p‐mediated suppression of PDGFRA may be used as a therapeutic intervention in the management of type 2 diabetes.

The up-regulation of miR-21 by gastrodin to promote the angiogenesis ability of human umbilical vein endothelial cells by activating the signaling pathway of PI3K/Akt

Based on network pharmacology, gastrodin attenuates hypertension-induced vascular smooth muscle cell proliferation and PI3K/AKT pathway activation

Gastrodin attenuates angiotensin II-induced vascular contraction and MLCK/p-MLC2 pathway activation

miR‐181a/b‐5p regulates human umbilical vein endothelial cell angiogenesis by targeting PDGFRA

Notoginsenoside R1 Protects HUVEC Against Oxidized Low Density Lipoprotein (Ox-LDL)-Induced Atherogenic Response via Down-Regulating miR-132

Upregulation of miR-181 a-5 p represses VEGF pathway in high glucose treated human retinal endothelial cells

Abstract 13480: High Density Lipoprotein Promotes Angiogenesis by Suppressing Mir-24-3p Expression

Gastrodin Alleviates Angiotensin II-Induced Hypertension and Myocardial Apoptosis via Inhibition of the PRDX2/p53 Pathway In Vivo and In Vitro

NEDD4L is a promoter for angiogenesis and cell proliferation in human umbilical vein endothelial cells

Gastrodin alleviates premature senescence of vascular endothelial cells by enhancing the Nrf2/HO-1 signalling pathway

Inhibition of vascular smooth muscle cell proliferation by serum from rats treated orally with Gastrodia and Uncaria decoction, a traditional Chinese formulation.

Andrographolide Protects against HG-Induced Inflammation, Apoptosis, Migration, and Impairment of Angiogenesis via PI3K/AKT-eNOS Signalling in HUVECs

Angiogenesis effect of therapeutic ultrasound on HUVECs through activation of the PI3K-Akt-eNOS signal pathway.

The pro-angiogenesis effect of miR33a-5p/Ets-1/DKK1 signaling in ox-LDL induced HUVECs

Downregulation of miR-210-3p attenuates high glucose-induced angiogenesis of vascular endothelial cells via targeting FGFRL1

Diterpenoid tanshinones inhibit gastric cancer angiogenesis through the PI3K/Akt/mTOR signaling pathway

MicroRNAs modulating angiogenesis: miR-129-1 and miR-133 act as angio-miR in HUVECs

MiR-181b suppresses angiogenesis by directly targeting cellular communication network factor 1

Mangiferin inhibits cell migration and angiogenesis via PI3K/AKT/mTOR signaling in high glucose‑ and hypoxia‑induced RRCECs

GLP-1 promotes angiogenesis in human endothelial cells in a dose-dependent manner, through the Akt, Src and PKC pathways

Angiogenin promotes angiogenesis via the endonucleolytic decay of miR-141 in colorectal cancer